Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect of Transphorm, Inc. from 31 Mar 2019 to 30 Jun 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Transphorm, Inc. quarterly and annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD history and change rate from 31 Mar 2019 to 30 Jun 2023.
  • Transphorm, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending 30 Jun 2023 was $12,716,000, a 239% decline year-over-year.
  • Transphorm, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was $17,908,000, a 173% decline from 2021.
  • Transphorm, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was $24,435,000, a 107% increase from 2020.
  • Transphorm, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2020 was $11,819,000.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Change (%)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Annual (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Annual Change (%)

Transphorm, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2023 $12,716,000 -$21,894,000 -239% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2024 Q1
Q2 2022 $9,178,000 +$16,216,000 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1
Q2 2021 $7,038,000 -$1,772,000 -34% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2023 Q1
Q1 2021 $5,194,000 -$16,967,000 -144% 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q2 2020 $5,266,000 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q1 2020 $11,773,000 +$12,335,000 01 Jan 2020 31 Mar 2020 10-KT 24 Jun 2021 2021 FY
Q1 2019 $562,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1

Transphorm, Inc. Annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $17,908,000 -$42,343,000 -173% 01 Apr 2022 31 Mar 2023 10-K 28 Jun 2023 2023 FY
2021 $24,435,000 +$12,616,000 +107% 01 Apr 2021 31 Mar 2022 10-K 28 Jun 2023 2023 FY
2020 $11,819,000 +$12,013,000 01 Jan 2020 31 Dec 2020 10-K 29 Jun 2022 2022 FY
2019 $194,000 01 Jan 2019 31 Dec 2019 10-KT 24 Jun 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.